David Sherbondy
Child & Adolescent Psychiatry · Greenville, SCNPI 1477572840
Payments from drug & device makers
Across 1,099 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Supernus Pharmaceuticals, Inc.$1K
- Sunovion Pharmaceuticals Inc.$1K
- Lundbeck LLC$1K
- plus $10K from 33 others
What the payments were for
- Food & beverage$19,016100%
- Education$890%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,105 in reported general payments places this provider in the 90th percentile of 71 child & adolescent psychiatry providers in South Carolina.
See all child & adolescent psychiatry providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EmsamSelegiline | 12 | $27,034 |
| RexultiBrexpiprazole | 12 | $18,011 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 96 | $10,594 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $8,643 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 17 | $8,296 |
| Buprenorphine Hcl | 70 | $3,506 |
| Duloxetine Hcl | 86 | $3,193 |
| Aripiprazole | 58 | $2,551 |
| Bupropion XlBupropion Hcl | 78 | $1,679 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 69 | $1,514 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 42 | $1,100 |
| Trazodone Hcl | 160 | $1,046 |
| Dextroamphetamine Sulfate ErDextroamphetamine Sulfate | 15 | $1,014 |
| Quetiapine Fumarate | 88 | $1,012 |
| Hydroxyzine Hcl | 48 | $623 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,577 | $18,01112 claims |
| Indivior Inc.Suboxone | $23 | $8,64315 claims |
| Orexo US, Inc.Zubsolv | $80 | $8,29617 claims |
| Almatica Pharma LLCSertraline Hcl | $504 | $36751 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 71 child & adolescent psychiatry providers in South Carolina.
Other child & adolescent psychiatry in Greenville
- Elena DlugachGreenville$8K
- Brittany RodgersGreenville$3K
- Elizabeth MasonGreenville$1K
- Deborah DavisGreenville$999
- Leah McCarttGreenville$658
- Michael SierraGreenville$483
- Amy JonesGreenville$282
- Sara Infield LavelleGreenville$224
- Lance FeldmanGreenville$190
- Dinorah GomezGreenville$150
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.